Tryptase and Protease-Activated Receptor 2 Expression Levels in Irritable Bowel Syndrome
0
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Background/Aims: Previous studies have revealed that mast cells (MCs) may activate the protease-activated receptors and release of neuropeptides involved in the pathogenesis of irritable bowel syndrome (IBS). The levels of proteaseactivated receptor 2 (PAR-2) and tryptase can contribute to understanding the pathogenesis of IBS. Methods: Colonoscopic biopsies were performed of 38 subjects (20 with IBSdiarrhea [IBS-D], eight with IBS-constipation [IBS-C], and 10 healthy volunteers). The mRNA and protein levels of tryptase and PAR-2 were assessed by real-time PCR and Western blot. The levels of vasoactive intestinal peptide (VIP), substance P (SP), and calcitonin gene-related peptide (CGRP) were measured by immunohistochemistry, and MCs were counted by toluidine blue staining. Results: Significant increases in the mRNA expression of tryptase (p<0.05, IBS-D, IBS-C vs control) and PAR-2 (p<0.05, IBS-D, IBS-C vs control) and in the tryptase protein level (p<0.05, IBS-D, IBS-C vs control) were detected in IBS. Elevations of MCs, CGRP, VIP and SP (p<0.05, IBS-D vs control) were observed for IBS-D only. Conclusions: Tryptase levels may upregulate the function of PAR- 2, resulting in the release of neuropeptide and they were correlated with clinical symptoms associated with IBS.
Abstract
Background/Aims: Previous studies have revealed that mast cells (MCs) may activate the protease-activated receptors and release of neuropeptides involved in the pathogenesis of irritable bowel syndrome (IBS). The levels of proteaseactivated receptor 2 (PAR-2) and tryptase can contribute to understanding the pathogenesis of IBS. Methods: Colonoscopic biopsies were performed of 38 subjects (20 with IBSdiarrhea [IBS-D], eight with IBS-constipation [IBS-C], and 10 healthy volunteers). The mRNA and protein levels of tryptase and PAR-2 were assessed by real-time PCR and Western blot. The levels of vasoactive intestinal peptide (VIP), substance P (SP), and calcitonin gene-related peptide (CGRP) were measured by immunohistochemistry, and MCs were counted by toluidine blue staining. Results: Significant increases in the mRNA expression of tryptase (p<0.05, IBS-D, IBS-C vs control) and PAR-2 (p<0.05, IBS-D, IBS-C vs control) and in the tryptase protein level (p<0.05, IBS-D, IBS-C vs control) were detected in IBS. Elevations of MCs, CGRP, VIP and SP (p<0.05, IBS-D vs control) were observed for IBS-D only. Conclusions: Tryptase levels may upregulate the function of PAR- 2, resulting in the release of neuropeptide and they were correlated with clinical symptoms associated with IBS.
참고문헌 (21)
- Martínez C, "Diarrhoea-predominant irritable bowel syndrome: an organic disorder with structural abnormalities in the jejunal epithelial barrier", Gut, 62, pp.1160~1168 (2013)
- Vivinus-Nébot M, "Combination of allergic factors can worsen diarrheic irritable bowel syndrome: role of barrier defects and mast cells", Am J Gastroenterol, 107, pp.75~81 (2012)
- Miller HR, "Tissue-specific expression of mast cell granule serine proteinases and their role in inflammation in the lung and gut", Immunology, 105, pp.375~390 (2002)
- Wilcz-Villega EM, "Mast cell tryptase reduces junctional adhesion molecule-A (JAM-A) expression in intestinal epithelial cells: implications for the mechanisms of barrier dysfunction in irritable bowel syndrome", Am J Gastroenterol, 108, pp.1140~1151 (2013)
- Cenac N, "Role for protease activity in visceral pain in irritable bowel syndrome", J Clin Invest, 117, pp.636~647 (2007)
- Oikonomopoulou K, "Kallikreinmediated cell signalling: targeting proteinase-activated receptors (PARs)", Biol Chem, 387, pp.817~824 (2006)
- Cenac N, "Induction of intestinal inflammation in mouse by activation of proteinase-activated receptor-2", Am J Pathol, 161, pp.1903~1915 (2002)
- Reed DE, "Mast cell tryptase and proteinase-activated receptor 2 induce hyperexcitability of guineapig submucosal neurons", J Physiol, 547(2), pp.531~542 (2003)
- Jacob C, "Mast cell tryptase controls paracellular permeability of the intestine: role of protease-activated receptor 2 and beta-arrestins", J Biol Chem, 280, pp.31936~31948 (2005)
- Fiorucci S, "Proteinase-activated receptor 2 is an anti-inflammatory signal for colonic lamina propria lymphocytes in a mouse model of colitis", Proc Natl Acad Sci U S A, 98, pp.13936~13941 (2001)
- Demir IE, "Neural plasticity in the gastrointestinal tract: chronic inflammation, neurotrophic signals, and hypersensitivity", Acta Neuropathol, 125, pp.491~509 (2013)
- Steinhoff M, "Agonists of proteinaseactivated receptor 2 induce inflammation by a neurogenic mechanism", Nat Med, 6, pp.151~158 (2000)
- Nozdrachev AD, "Changes in afferent impulse activity of small intestine mesenteric nerves in response to antigen challenge", Neuroscience, 94, pp.1339~1342 (1999)
- Bueno L, "Mediators and pharmacology of visceral sensitivity: from basic to clinical investigations", Gastroenterology, 112, pp.1714~1743 (1997)
- Barbara G, "Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome", Gastroenterology, 126, pp.693~702 (2004)
- Corvera CU, "Mast cell tryptase regulates rat colonic myocytes through proteinase-activated receptor2", J Clin Invest, 100, pp.1383~1393 (1997)
- Duerksen DR, "Intestinal permeability in long-term follow-up of patients with celiac disease on a glutenfree diet", Dig Dis Sci, 50, pp.785~790 (2005)
- Coelho AM, "Proteinases and proteinase-activated receptor 2: a possible role to promote visceral hyperalgesia in rats", Gastroenterology, 122, pp.1035~1047 (2002)
- Lee JW, "Subjects with diarrhea-predominant IBS have increased rectal permeability responsive to tryptase", Dig Dis Sci, 55, pp.2922~2928 (2010)
- 김동훈, "Stress-induced Alterations in Mast Cell Numbers and Proteinaseactivated Receptor-2 Expression of the Colon: Role of Corticotrophin-releasing Factor", Journal of Korean Medical Science, 25(9), pp.1330~1335 (2010), 대한의학회
- Bian ZX, "Unbalanced expression of protease-activated receptors-1 and -2 in the colon of diarrhea-predominant irritable bowel syndrome patients", J Gastroenterol, 44, pp.666~674 (2009)